Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model

The Journal of Antimicrobial Chemotherapy
Bao CaoClaus Moser

Abstract

Treating biofilm infections successfully is a challenge. We hypothesized that biofilms may be considered as independent compartments with particular pharmacokinetics. We therefore studied the pharmacokinetics and pharmacodynamics of tobramycin in a seaweed alginate-embedded biofilm model. Seaweed alginate beads containing Pseudomonas aeruginosa were cultured in LB medium, sampled at day 1, 3, 5 or 7 and examined for the effect of treatment with tobramycin for 30 min. Treated beads were homogenized and the number of cfu was determined. The antibiotic concentration in the solution of homogenized beads was measured. Finally, beads were examined for live cells by Syto9 staining and for dead cells by propidium iodide staining using a confocal laser scanning microscope. The antibiotic level in each bead was relatively stable (range 30-42 mg/L; MIC = 1.5 mg/L). There were fewer cfu in the tobramycin-treated beads than the non-treated beads (P < 0.016) and bacterial killing was reduced as the culture period increased from 1 to 7 days. Throughout the study period, increasing size and more superficial positioning of the microcolonies within the beads were demonstrated by confocal laser scanning microscopy. More dead cells (measured by pr...Continue Reading

References

Apr 1, 1988·Antimicrobial Agents and Chemotherapy·W W NicholsH L Walmsley
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·P A SuciG G Geesey
Oct 6, 1998·Applied and Environmental Microbiology·K D XuG A McFeters
Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·L CoquetT Jouenne
May 21, 1999·Science·J W CostertonE P Greenberg
Aug 28, 2002·International Journal of Medical Microbiology : IJMM·Philip S Stewart
Apr 21, 2009·Cellular Microbiology·Luanne Hall-Stoodley, Paul Stoodley
May 20, 2009·Antimicrobial Agents and Chemotherapy·Philip S StewartJudith N Steenbergen
Jun 29, 2010·FEMS Immunology and Medical Microbiology·Peter Østrup JensenClaus Moser
Jul 7, 2010·FEMS Immunology and Medical Microbiology·Mette BurmølleThomas Bjarnsholt
Jan 6, 2011·FEMS Immunology and Medical Microbiology·John William CostertonPatrick DeMeo
Apr 13, 2011·International Journal of Oral Science·Niels HøibyThomas Bjarnsholt
Jun 15, 2011·Antimicrobial Agents and Chemotherapy·Wang HengzhuangNiels Høiby
Sep 13, 2011·Annals of Intensive Care·Christophe Bordi, Sophie de Bentzmann
Feb 23, 2012·Antimicrobial Agents and Chemotherapy·Wang HengzhuangNiels Høiby
Apr 4, 2012·FEMS Immunology and Medical Microbiology·Luanne Hall-StoodleyThomas Bjarnsholt
May 3, 2012·FEMS Immunology and Medical Microbiology·Thomas BjarnsholtÅke Försberg
Oct 3, 2012·Journal of Internal Medicine·U Römling, C Balsalobre
Mar 13, 2013·Antimicrobial Agents and Chemotherapy·Wen-Chi ChiangTim Tolker-Nielsen
Jul 6, 2013·Trends in Microbiology·Thomas BjarnsholtNiels Høiby
Sep 21, 2013·Intensive Care Medicine·Andrew A UdyJeffrey Lipman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society
Hannah TrøstrupClaus Moser
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
S TakenakaE Hoshino
© 2021 Meta ULC. All rights reserved